Transition: Difference between revisions

1,180 bytes added ,  1 year ago
m
Bot: adding archive links to references (error log).
m (Bot: adding archive links to references (error log).)
Line 39: Line 39:


<!--T:15-->
<!--T:15-->
''“...Young people are eligible for treatment in the adult NHS clinics (once they are 18 years old) or by private practitioners (from 16 years old)”'' <ref>http://www.gires.org.uk/assets/DOH-Assets/pdf/doh-children-and-adolescents.pdf</ref>.
''“...Young people are eligible for treatment in the adult NHS clinics (once they are 18 years old) or by private practitioners (from 16 years old)”'' <ref>http://www.gires.org.uk/assets/DOH-Assets/pdf/doh-children-and-adolescents.pdf [https://web.archive.org/web/20230310110222/http://www.gires.org.uk/assets/DOH-Assets/pdf/doh-children-and-adolescents.pdf Archived] on 17 July 2023</ref>.


==Changing your name== <!--T:16-->
==Changing your name== <!--T:16-->
Line 55: Line 55:


<!--T:21-->
<!--T:21-->
Changing one's name within an everyday social context can be as simple as informing others of one's choice. However, in societies with a complex legal system (or equivalent), there can be conditions that place limitations on the individual's right to self determination, which can be especially problematic for [[nonbinary]] individuals. For example, in Germany the Standesamt (Office of Vital Statistics) <ref>http://standesamtauskunft.de/Default2.aspx</ref> typically refuses to recognise in German civil registration law names that are gender-ambiguous; a given name must indicate that the owner is either 'male' or 'female'.
Changing one's name within an everyday social context can be as simple as informing others of one's choice. However, in societies with a complex legal system (or equivalent), there can be conditions that place limitations on the individual's right to self determination, which can be especially problematic for [[nonbinary]] individuals. For example, in Germany the Standesamt (Office of Vital Statistics) <ref>http://standesamtauskunft.de/Default2.aspx [https://web.archive.org/web/20210920205748/https://standesamtauskunft.de/Default2.aspx Archived] on 17 July 2023</ref> typically refuses to recognise in German civil registration law names that are gender-ambiguous; a given name must indicate that the owner is either 'male' or 'female'.


=====State of Address===== <!--T:22-->
=====State of Address===== <!--T:22-->
Line 109: Line 109:


<!--T:92-->
<!--T:92-->
Puberty blockers are drugs that postpone or temporarily suspend puberty in children and teenagers. They are used for [[transgender]] children, including those who identify as [[nonbinary]], to stop the development of features that they consider to mark the wrong sex,<ref name=":0">{{Cite journal|last=Stevens|first=Jaime|last2=Gomez-Lobo|first2=Veronica|last3=Pine-Twaddell|first3=Elyse|date=2015-12-01|title=Insurance Coverage of Puberty Blocker Therapies for Transgender Youth|url=http://pediatrics.aappublications.org/content/136/6/1029|journal=Pediatrics|language=en|volume=136|issue=6|pages=1029–1031|doi=10.1542/peds.2015-2849|issn=0031-4005|pmid=26527547|doi-access=free}}</ref><ref>{{cite web |url=http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ |title=Looking at suppressing puberty for transgender kids |publisher=Associated Press |date=March 12, 2016}}</ref><ref>{{cite web |url=https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ |title=Transgender Youth Using Puberty Blockers |publisher=[[KQED]] |date=August 19, 2016}}</ref> with the intent to provide transgender youth more time to explore their identity.<ref name=":1">{{Cite journal|last=Alegría|first=Christine Aramburu|date=2016-10-01|title=Gender nonconforming and transgender children/youth: Family, community, and implications for practice|journal=Journal of the American Association of Nurse Practitioners|language=en|volume=28|issue=10|pages=521–527|doi= 10.1002/2327-6924.12363|pmid=27031444|issn=2327-6924}}</ref> the studies that have been conducted indicate that these treatments are reasonably safe, and can improve psychological well-being in these individuals.<ref name="lancet_pubertyblockers">{{cite journal | last=Mahfouda | first=Simone | last2=Moore | first2=Julia K | last3=Siafarikas | first3=Aris | last4=Zepf | first4=Florian D | last5=Lin | first5=Ashleigh | title=Puberty suppression in transgender children and adolescents | journal=The Lancet Diabetes & Endocrinology | publisher=Elsevier BV | volume=5 | issue=10 | year=2017 | issn=2213-8587 | doi=10.1016/s2213-8587(17)30099-2 | pmid=28546095 | pages=816–826 | ref=harv|quote=The few studies that have examined the psychological effects of suppressing puberty, as the first stage before possible future commencement of CSH therapy, have shown benefits."}}</ref><ref>{{cite journal |last1=Rafferty |first1=Jason |title=Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents |journal=Pediatrics |date=October 2018 |volume=142 |issue=4 |pages=e20182162 |url=https://pediatrics.aappublications.org/content/142/4/e20182162 |accessdate=23 July 2019|quote=Often, pubertal suppression...reduces the need for later surgery because physical changes that are otherwise irreversible (protrusion of the Adam’s apple, male pattern baldness, voice change, breast growth, etc) are prevented. The available data reveal that pubertal suppression in children who identify as TGD generally leads to improved psychological functioning in adolescence and young adulthood.|doi=10.1542/peds.2018-2162 |pmid=30224363 |doi-access=free }}</ref><ref name="Hembree_et_al">{{cite journal |last1=Hembree |first1=Wylie C |last2=Cohen-Kettenis |first2=Peggy T |last3=Gooren |first3=Louis |last4=Hannema |first4=Sabine E |last5=Meyer |first5=Walter J |last6=Murad |first6=M Hassan |last7=Rosenthal |first7=Stephen M |last8=Safer |first8=Joshua D |last9=Tangpricha |first9=Vin |last10=T'Sjoen |first10=Guy G |title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline |journal=The Journal of Clinical Endocrinology & Metabolism |date=November 2017 |volume=102 |issue=11 |page=3881|quote=Treating GD/gender-incongruent adolescents entering puberty with GnRH analogs has been shown to improve psychological functioning in several domains|doi=10.1210/jc.2017-01658 |pmid=28945902 |doi-access=free }}</ref> In 2019, a study in the journal ''Pediatrics'' found that access to pubertal suppression during adolescence was associated with a lower odds of lifetime suicidality among transgender people.<ref>{{cite journal |last1=Turban |first1=Jack |title=Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation |journal=Pediatrics |date=February 2020 |volume=145 |issue=2 |page=e2019172 |doi=10.1542/peds.2019-1725 |pmid=31974216 |url=https://pediatrics.aappublications.org/content/145/2/e20191725 |accessdate=11 February 2020|pmc=7073269 }}</ref>
Puberty blockers are drugs that postpone or temporarily suspend puberty in children and teenagers. They are used for [[transgender]] children, including those who identify as [[nonbinary]], to stop the development of features that they consider to mark the wrong sex,<ref name=":0">{{Cite journal|last=Stevens|first=Jaime|last2=Gomez-Lobo|first2=Veronica|last3=Pine-Twaddell|first3=Elyse|date=2015-12-01|title=Insurance Coverage of Puberty Blocker Therapies for Transgender Youth|url=http://pediatrics.aappublications.org/content/136/6/1029|journal=Pediatrics|language=en|volume=136|issue=6|pages=1029–1031|doi=10.1542/peds.2015-2849|issn=0031-4005|pmid=26527547|doi-access=free|archive-url=https://web.archive.org/web/20230628170532/http://pediatrics.aappublications.org/content/136/6/1029|archive-date=17 July 2023}}</ref><ref>{{cite web |url=http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ |title=Looking at suppressing puberty for transgender kids |publisher=Associated Press |date=March 12, 2016|archive-url=https://web.archive.org/web/20230617205749/http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ |archive-date=17 July 2023 }}</ref><ref>{{cite web |url=https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ |title=Transgender Youth Using Puberty Blockers |publisher=[[KQED]] |date=August 19, 2016|archive-url=https://web.archive.org/web/20221211205947/https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ |archive-date=17 July 2023 }}</ref> with the intent to provide transgender youth more time to explore their identity.<ref name=":1">{{Cite journal|last=Alegría|first=Christine Aramburu|date=2016-10-01|title=Gender nonconforming and transgender children/youth: Family, community, and implications for practice|journal=Journal of the American Association of Nurse Practitioners|language=en|volume=28|issue=10|pages=521–527|doi= 10.1002/2327-6924.12363|pmid=27031444|issn=2327-6924}}</ref> the studies that have been conducted indicate that these treatments are reasonably safe, and can improve psychological well-being in these individuals.<ref name="lancet_pubertyblockers">{{cite journal | last=Mahfouda | first=Simone | last2=Moore | first2=Julia K | last3=Siafarikas | first3=Aris | last4=Zepf | first4=Florian D | last5=Lin | first5=Ashleigh | title=Puberty suppression in transgender children and adolescents | journal=The Lancet Diabetes & Endocrinology | publisher=Elsevier BV | volume=5 | issue=10 | year=2017 | issn=2213-8587 | doi=10.1016/s2213-8587(17)30099-2 | pmid=28546095 | pages=816–826 | ref=harv|quote=The few studies that have examined the psychological effects of suppressing puberty, as the first stage before possible future commencement of CSH therapy, have shown benefits."}}</ref><ref>{{cite journal |last1=Rafferty |first1=Jason |title=Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents |journal=Pediatrics |date=October 2018 |volume=142 |issue=4 |pages=e20182162 |url=https://pediatrics.aappublications.org/content/142/4/e20182162 |accessdate=23 July 2019|quote=Often, pubertal suppression...reduces the need for later surgery because physical changes that are otherwise irreversible (protrusion of the Adam’s apple, male pattern baldness, voice change, breast growth, etc) are prevented. The available data reveal that pubertal suppression in children who identify as TGD generally leads to improved psychological functioning in adolescence and young adulthood.|doi=10.1542/peds.2018-2162 |pmid=30224363 |doi-access=free |archive-url=https://web.archive.org/web/20230614175518/https://pediatrics.aappublications.org/content/142/4/e20182162 |archive-date=17 July 2023 }}</ref><ref name="Hembree_et_al">{{cite journal |last1=Hembree |first1=Wylie C |last2=Cohen-Kettenis |first2=Peggy T |last3=Gooren |first3=Louis |last4=Hannema |first4=Sabine E |last5=Meyer |first5=Walter J |last6=Murad |first6=M Hassan |last7=Rosenthal |first7=Stephen M |last8=Safer |first8=Joshua D |last9=Tangpricha |first9=Vin |last10=T'Sjoen |first10=Guy G |title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline |journal=The Journal of Clinical Endocrinology & Metabolism |date=November 2017 |volume=102 |issue=11 |page=3881|quote=Treating GD/gender-incongruent adolescents entering puberty with GnRH analogs has been shown to improve psychological functioning in several domains|doi=10.1210/jc.2017-01658 |pmid=28945902 |doi-access=free }}</ref> In 2019, a study in the journal ''Pediatrics'' found that access to pubertal suppression during adolescence was associated with a lower odds of lifetime suicidality among transgender people.<ref>{{cite journal |last1=Turban |first1=Jack |title=Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation |journal=Pediatrics |date=February 2020 |volume=145 |issue=2 |page=e2019172 |doi=10.1542/peds.2019-1725 |pmid=31974216 |url=https://pediatrics.aappublications.org/content/145/2/e20191725 |accessdate=11 February 2020|pmc=7073269 |archive-url=https://web.archive.org/web/20230604181439/https://pediatrics.aappublications.org/content/145/2/e20191725 |archive-date=17 July 2023 }}</ref>


===Change your voice=== <!--T:33-->
===Change your voice=== <!--T:33-->
Line 182: Line 182:


<!--T:113-->
<!--T:113-->
Periods are often a source of distressing [[gender dysphoria]] for nonbinary people who were [[sexes#assigned female at birth|assigned female at birth]]. There are several ways of preventing periods:<ref>{{Cite journal|last=Carswell|first=Jeremi M.|last2=Roberts|first2=Stephanie A.|date=December 2017|title=Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents|url=http://www.liebertpub.com/doi/10.1089/trgh.2017.0021|journal=Transgender Health|language=en|volume=2|issue=1|pages=195–201|doi=10.1089/trgh.2017.0021|issn=2380-193X|pmc=PMC5684657|pmid=29142910}}</ref>
Periods are often a source of distressing [[gender dysphoria]] for nonbinary people who were [[sexes#assigned female at birth|assigned female at birth]]. There are several ways of preventing periods:<ref>{{Cite journal|last=Carswell|first=Jeremi M.|last2=Roberts|first2=Stephanie A.|date=December 2017|title=Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents|url=http://www.liebertpub.com/doi/10.1089/trgh.2017.0021|journal=Transgender Health|language=en|volume=2|issue=1|pages=195–201|doi=10.1089/trgh.2017.0021|issn=2380-193X|pmc=PMC5684657|pmid=29142910|archive-url=https://web.archive.org/web/20230410073008/https://www.liebertpub.com/doi/10.1089/trgh.2017.0021|archive-date=17 July 2023}}</ref>
* [[Transmasculine hormone therapy]], such as [[Testosterone]]: Testosterone will prevent periods (although the changes won't be immediate).
* [[Transmasculine hormone therapy]], such as [[Testosterone]]: Testosterone will prevent periods (although the changes won't be immediate).
* [[Progestogens]], such as birth control pills: these will also prevent (or, at least, decrease) periods, although they are not as effective as testosterone. However, they won't cause masculinisation.  
* [[Progestogens]], such as birth control pills: these will also prevent (or, at least, decrease) periods, although they are not as effective as testosterone. However, they won't cause masculinisation.  
1,235

edits